As of June 5, 2017, the BCCSU is responsible for the educational and clinical care guidance activities for all health care professionals who are prescribing medications to treat opioid addiction (i.e., methadone, buprenorphine/naloxone, slow-release oral morphine). This includes the authorization process for those seeking an exemption under Section 56 of the Controlled Drugs and Substances Act to prescribe methadone.
It is important to note that the exemption process for prescribers of methadone for analgesic purposes is the responsibility of the College of Physicians and Surgeons of BC. In order to improve access and provincial capacity for opioid agonist treatment education for health professionals, the BCCSU is transitioning to an online learning environment paired with an in-person preceptorship for the Provincial Opioid Addiction Treatment Support Program.
- 8-hour online course (which includes both MainPro+ and MOC CME credits)
- 2 half-days of preceptorship, or additional learning as needed (with BCCSU-approved preceptor)
- PharmaNet review
- Temporary Methadone prescribing (includes temporary methadone exemption) – specific modules and PharmaNet review
- Methadone CME – Methadone modules only
- Buprenorphine/naloxone CME – Buprenorphine/naloxone modules only
- Full CME – All online modules
- Educational only – One or more modules of choice
- Trauma-Informed Care
- Overview of Opioid Use Disorder
- Triage, Assessment, and Treatment Planning
- Urine Drug Testing
- Harm Reduction
- Health Promotion for People with Opioid Use Disorder
- Methadone – Pharmacotherapy, Safety, Continuing Care, and Pregnancy
- Buprenorphine/Naloxone – Pharmacotherapy, Induction, Continuing Care, and Pregnancy
- Slow Release Oral Morphine (SROM)
- Caring for a Patient with Opioid Use Disorder
- Differences Between Methadone and Buprenorphine
- Treating Opioid Use Disorder – Rural Context
- Home Induction of Buprenorphine/Naloxone
- Polysubstance Use While on Opioid Agonist Treatment
- Strategies to Prevent Diversion
- Benzodiazepine Prescribing from Another Prescriber
- Youth with Opioid Use Disorder
- Managing Precipitated Withdrawal - Buprenorphine/Naloxone
- Methadone in Acute Care Settings
- Buprenorphine/Naloxone in Acute Care Settings
- Transition from Methadone to Buprenorphine/Naloxone
FAQS - Provincial Opioid Addiction Treatment Support Program
Preceptors will assist in the training and mentoring of new prescribers. The BCCSU has developed a process to select preceptors across the province (i.e. each health authority) to ensure adequate coverage to meet the needs for recruiting new prescribers, including nurse practitioners.
BCCSU preceptors must meet the following criteria:
- At least three years’ experience in the Methadone Maintenance Program with minimum 20 registered patients and a practice that includes routine inductions
- An acceptable PharmaNet review (as per the CPSBC Standards and Guidelines for Safe Prescribing of Drugs with Potential for Misuse/Diversion)
- Clinical practice adherence to the BCCSU’s Guideline for the Clinical Management of Opioid Use Disorder
Preceptors will be provided with comprehensive training regarding their role and responsibilities. Further, preceptors will be compensated $200 per half-day of teaching and for training sessions required by the BCCSU.
At this time, an exemption is not required to prescribe buprenorphine/naloxone. Providers interested in prescribing buprenorphine/naloxone are strongly encouraged to complete the modules pertaining to this medication (CME accredited) before starting to prescribe. In addition to the online modules, the RACE line is also available to provide additional addiction medicine expert support.